Clinical Case Discussion: Intermediate-risk Prostate Cancer: The Case for Active Surveillance

Marc Dall'Era, Benjamin J. Davies

Research output: Contribution to journalComment/debate

Abstract

Active surveillance offers men the opportunity to defer immediate local treatment of low risk prostate cancer while preserving a highly functional quality of life. Novel biomarkers and imaging technology will enable physicians to better identify ideal candidates for this approach beyond traditional clinical characteristics.

Original languageEnglish (US)
Pages (from-to)208-209
Number of pages2
JournalEuropean Urology Focus
Volume1
Issue number2
DOIs
StatePublished - Sep 1 2015

    Fingerprint

ASJC Scopus subject areas

  • Urology

Cite this